Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production ...

With his three decades of experience in healthcare and technology companies, Gilad will play a pivotal role in the execution of our growth strategy, and I am delighted to welcome him to the Protalix ...

Scientists in Denmark have found the solution to a key issue holding back precision-fermented casein proteins, paving the way ...

Bacteria are set to transform the future of dairy-free milk products. Scientists have successfully engineered E. coli to ...

The National Medical Products Administration approved the marketing of a rice-derived recombinant human albumin injection on ...

The global recombinant proteins market size was US$ 1.5 billion in 2021. The global recombinant proteins market is forecasted to grow to US$ 4 billion by 2030 by registering a compound annual growth ...

Sino Biological launches endotoxin-free recombinant proteins, ProPure: Houston, Texas Tuesday, July 15, 2025, 17:00 Hrs [IST] Sino Biological US, Inc, an international reagent sup ...

Australian precision fermentation startup Eclipse Ingredients has emerged from stealth with A$7M ($4.6M) in funding to scale ...

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin ...

Sino Biological US, Inc. proudly unveils ProPure(TM), an industry-leading line of ultra-pure, endotoxin-free recombinant proteins, fully produced in the USA at its state-of-the-art Center for ...

This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.